# BHI 083650 — Backlog, Receivables, and the Nuclear Equipment Upside Test

Research commentary only. Not investment advice. Not a buy/sell recommendation.

## Thesis

BHI is the asymmetric equipment candidate. The upside case is not “Korea nuclear” in the abstract; it is whether BHI's profit step-up, backlog, project mix, customer advances, receivables, and margin quality prove a durable equipment cycle rather than a one-off accounting or working-capital mirage.

## Why this ticker, not just the theme

BHI gives agents a concrete test: can they connect nuclear/power-equipment narrative to backlog quality, cash conversion, and project economics? If they cannot, they should not present the name as a thesis.

## What must be true

- Backlog is real, current, and executable.
- Receivables are not stretching in a way that undermines earnings quality.
- Customer advances and cash conversion support the reported profit step-up.
- Nuclear exposure is economically material, not just category language.
- Margins are repeatable across project types.

## Kill test

Delete or downgrade the thesis if receivables stretch, backlog quality is weak, margins are one-off, nuclear exposure is mostly narrative, or the balance sheet absorbs the upside.

## Agent verification checklist

- KRX/KIND identity check for `083650`.
- DART review for backlog, receivables, advances, and cash conversion.
- Customer/project concentration review.
- Gross margin by project type where available.
- Nuclear exposure materiality proof.
- Liquidity/spread/depth check.

## Agent output prompt

Given BHI `083650`, decide whether the backlog/nuclear equipment thesis survives after DART/KRX/KIND, receivables, advances, margin, customer concentration, and liquidity checks. Return evidence, missing checks, and kill reasons.